Exact Sciences asks FDA to approve 'Cologuard 2.0'
A company developing a rival colon cancer test, which was sued by Exact Sciences in November over alleged patent infringement, has asked for a review of the patent.
Source: chippewa.com
Page 2 - Madison Based Exact Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Madison Based Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Madison Based Exact Sciences Today - Breaking & Trending Today
Exact Sciences asks FDA to approve 'Cologuard 2.0'
A company developing a rival colon cancer test, which was sued by Exact Sciences in November over alleged patent infringement, has asked for a review of the patent.
Source: madison.com
Exact Sciences turns small profit in Q3 after big losses
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported third-quarter net income of $0.8 million, or $0.00 per share, on revenue of $628 million.
Source: lacrossetribune.com
Exact Sciences turns small profit in Q3 after big losses
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported third-quarter net income of $0.8 million, or $0.00 per share, on revenue of $628 million.
Source: chippewa.com
Exact Sciences' Q2 results beat analysts' expectations
The biomedical giant best known for its Cologuard test reported a second-quarter loss of $81 million, or 45 cents per share, on revenue of $622.1 million.
Source: lacrossetribune.com